Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Cancers|April 14, 2019
Cancer Vaccines Co-Targeting HER2/Neu and IGF1RCarla De Giovanni, Lorena Landuzzi, Arianna Palladini, et al.
Cell Communication and Signaling : CCS|October 11, 2024
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes?Francesca Ruzzi, Chiara Cappello, Maria Sofia Semprini, et al.
European Journal of Cancer (Oxford, England : 1990)|December 6, 2005
Targeting CD99 in association with doxorubicin: an effective combined treatment for Ewing's sarcomaKatia Scotlandi, Stefania Perdichizzi, Ghislaine Bernard, et al.
Plos Pathogens|August 7, 2018
A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumorsValerio Leoni, Andrea Vannini, Valentina Gatta, et al.
Oncoimmunology|September 18, 2018
OX40 triggering concomitant to IL12-engineered cell vaccine hampers the immunoprevention of HER2/neu-driven mammary carcinogenesisPatrizia Nanni, Carla De Giovanni, Alessia Burocchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2007
Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcomaMaria C Manara, Lorena Landuzzi, Patrizia Nanni, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2005
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenarioAnnalisa Astolfi, Simona Rolla, Patrizia Nanni, et al.
Cancer Research|November 19, 2004
Immunological prevention of a multigene cancer syndromeStefania Croci, Giordano Nicoletti, Lorena Landuzzi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccineAlberto Comes, Ombretta Rosso, Anna Maria Orengo, et al.
Frontiers in Pharmacology|December 1, 2025
Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 responseChiara Cappello, Francesca Ruzzi, Julia Consoli, et al.
Pageof 8